Author Jeffrey Hill offers updates on Walgreens' and competitor CVS' moves to sell CBD products in-store, part of the former's overarching strategy to better meet customer needs and diversify product range

Walgreens is the latest major pharmacy chain to announce it will carry hemp-based CBD products. The retailer is set to begin selling CBD topical products in about 1,500 stores in 10 states, according to a CNBC report. The news comes on the heels of its competitor CVS announcing last week it would begin selling similar products in its stores throughout eight states.

If you are following the chain drug industry, you know that CVS is very focused on becoming the “preferred health focused drug chain.” The brand dropped cigarette sales and is integrating more basic health testing and offerings into its new stores. Walgreens is executing its own strategy  involving  much more organic growth than CVS (who is really a “chain of chains”), brought into New York City via acquiring Duane Reade, the last bastion of NYC retail drug.

READ THIS ARTICLE FOR $15
$15 provides access to this article and every case-study, interview, and analysis piece that we publish for the next 30 days. Our Premium Subscription also provides access to a database of over 100,000 articles on innovation in brand, customer, and retail experience.
Already a subscriber? Log in